DiaMedica Therapeutics Inc.
DMAC | NASDAQ
$7.26
+$0.41 (+5.99%)
At close: Sep 21, 2026, 4:00 PM ET
$7.26
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.13M | -10.48M | -9.21M | -9.03M | -8.01M | -8.14M | -8.42M | -6.88M | -5.64M | -5.74M | -5.85M | -5.16M | -4.74M | -5.52M | -3.97M | -3.13M | -3.36M | -3.54M | -3.25M | -3.42M | -3.37M | -3.62M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 353K | n/a | n/a | 35K | n/a | n/a | n/a | 4K |
Pretax Income | -10.13M | -10.04M | -8.73M | -8.61M | -7.69M | -7.7M | -7.89M | -6.27M | -5.11M | -5.14M | -5.14M | -4.46M | -4.47M | -5.27M | -3.74M | -3.05M | -3.35M | -3.5M | -3.24M | -3.44M | -3.27M | -3.62M |
Net Income | -10.14M | -10.04M | -8.74M | -8.62M | -7.7M | -7.71M | -7.9M | -6.27M | -5.12M | -5.15M | -5.16M | -4.47M | -4.48M | -5.27M | -3.75M | -3.06M | -3.36M | -3.51M | -3.25M | -3.45M | -3.27M | -3.62M |
Selling & General & Admin | 2.35M | 2.5M | 2.51M | 2.6M | 2.19M | 2.49M | 1.95M | 1.9M | 1.71M | 2.07M | 2.17M | 1.89M | 2.2M | 1.9M | 1.7M | 1.49M | 1.41M | 1.56M | 1.38M | 1.08M | 1.21M | 1.21M |
Research & Development | 8.15M | 7.99M | 6.7M | 6.44M | 5.82M | 5.66M | 6.47M | 4.98M | 3.93M | 3.68M | 3.68M | 3.27M | 2.54M | 3.62M | 2.27M | 1.64M | 1.96M | 1.97M | 1.87M | 2.33M | 2.16M | 2.41M |
Other Expenses | -366K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.13M | 10.48M | 9.21M | 9.03M | 8.01M | 8.14M | 8.42M | 6.88M | 5.64M | 5.74M | 5.85M | 5.16M | 4.74M | 5.52M | 3.97M | 3.13M | 3.36M | 3.54M | 3.25M | 3.42M | 3.37M | 3.62M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 159K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.13M | 10.48M | 9.21M | 9.03M | 8.01M | 8.14M | 8.42M | 6.88M | 5.64M | 5.74M | 5.85M | 5.16M | 4.74M | 5.52M | 3.97M | 3.13M | 3.36M | 3.54M | 3.25M | 3.42M | 3.37M | 3.62M |
Income Tax Expense | 7K | -7K | 10K | 6K | 6K | 6K | 9K | 7K | 7K | 7K | 22K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K |
Shares Outstanding (Basic) | 53.89M | 53.79M | 46.98M | 49.63M | 42.96M | 42.84M | 42.82M | 42.75M | 38.07M | 37.96M | 37.96M | 37.95M | 27.31M | 26.45M | 26.44M | 26.44M | 26.44M | 26.44M | 19.04M | 19.04M | 18.79M | 18.77M |
Shares Outstanding (Diluted) | 53.89M | 53.79M | 46.98M | 49.63M | 42.96M | 42.84M | 42.82M | 42.75M | 38.07M | 37.96M | 37.96M | 37.95M | 27.31M | 26.45M | 26.44M | 26.44M | 26.44M | 26.44M | 19.04M | 19.04M | 18.79M | 18.77M |
EPS (Basic) | -0.19 | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 | -0.13 | -0.14 | -0.14 | -0.12 | -0.16 | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 | -0.17 | -0.18 | -0.17 | -0.19 |
EPS (Diluted) | -0.19 | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 | -0.13 | -0.14 | -0.14 | -0.12 | -0.16 | -0.20 | -0.14 | -0.12 | -0.13 | -0.13 | -0.17 | -0.18 | -0.17 | -0.19 |
EBITDA | -9.75M | -10.02M | -8.72M | -8.6M | -7.69M | -7.69M | -7.88M | -6.26M | -5.1M | -5.14M | -5.13M | -4.46M | -4.46M | -5.26M | -3.58M | -3.05M | -3.35M | -3.5M | -3.23M | -3.44M | -3.26M | -3.61M |
EBIT | -10.13M | -10.04M | -8.73M | -8.61M | -7.69M | -7.7M | -7.89M | -6.27M | -5.11M | -5.14M | -5.14M | -4.46M | -4.47M | -5.27M | -3.59M | -3.05M | -3.35M | -3.5M | -3.24M | -3.44M | -3.27M | -3.62M |
Depreciation & Amortization | 382K | 11K | 11K | 18K | 3K | 11K | 11K | 10K | 10K | 8K | 8K | 8K | 7K | 7K | 6K | 7K | 6K | 6K | 6K | 6K | 6K | 6K |
Add to Watchlist
Select watchlists to add or remove DMAC